BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8219209)

  • 1. Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes.
    Repka T; Shalev O; Reddy R; Yuan J; Abrahamov A; Rachmilewitz EA; Low PS; Hebbel RP
    Blood; 1993 Nov; 82(10):3204-10. PubMed ID: 8219209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo.
    Shalev O; Repka T; Goldfarb A; Grinberg L; Abrahamov A; Olivieri NF; Rachmilewitz EA; Hebbel RP
    Blood; 1995 Sep; 86(5):2008-13. PubMed ID: 7655028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonheme iron in sickle erythrocyte membranes: association with phospholipids and potential role in lipid peroxidation.
    Kuross SA; Hebbel RP
    Blood; 1988 Oct; 72(4):1278-85. PubMed ID: 3167208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation.
    Kuross SA; Rank BH; Hebbel RP
    Blood; 1988 Apr; 71(4):876-82. PubMed ID: 3355895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The instability of the membrane skeleton in thalassemic red blood cells.
    Yuan J; Bunyaratvej A; Fucharoen S; Fung C; Shinar E; Schrier SL
    Blood; 1995 Nov; 86(10):3945-50. PubMed ID: 7579365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalysis of soluble hemoglobin oxidation by free iron on sickle red cell membranes.
    Shalev O; Hebbel RP
    Blood; 1996 May; 87(9):3948-52. PubMed ID: 8611725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indices of membrane alterations in beta-thalassemic erythrocytes.
    Tavazzi D; Comino A; Turrini F; Fiorelli G; Cappellini MD
    Hemoglobin; 1998; 22(5-6):483-92. PubMed ID: 9859931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane heme as a host factor in reducing effectiveness of dihydroartemisinin.
    Vattanaviboon P; Siritanaratkul N; Ketpirune J; Wilairat P; Yuthavong Y
    Biochem Pharmacol; 2002 Jul; 64(1):91-8. PubMed ID: 12106609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease.
    Nagababu E; Fabry ME; Nagel RL; Rifkind JM
    Blood Cells Mol Dis; 2008; 41(1):60-6. PubMed ID: 18262448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes.
    Scott MD; van den Berg JJ; Repka T; Rouyer-Fessard P; Hebbel RP; Beuzard Y; Lubin BH
    J Clin Invest; 1993 Apr; 91(4):1706-12. PubMed ID: 7682576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular pathobiology of cell membrane iron: the sickle red cell as a model.
    Browne P; Shalev O; Hebbel RP
    Free Radic Biol Med; 1998 Apr; 24(6):1040-8. PubMed ID: 9607615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative denaturation of red blood cells in thalassemia.
    Shinar E; Rachmilewitz EA
    Semin Hematol; 1990 Jan; 27(1):70-82. PubMed ID: 2405497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence measurements of the labile iron pool of sickle erythrocytes.
    Darbari D; Loyevsky M; Gordeuk V; Kark JA; Castro O; Rana S; Apprey V; Kurantsin-Mills J
    Blood; 2003 Jul; 102(1):357-64. PubMed ID: 12623854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound hemoglobin in the erythrocytes of sickle cell anemia.
    Sears DA; Luthra MG
    J Lab Clin Med; 1983 Nov; 102(5):694-8. PubMed ID: 6631167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes.
    Spector J; Kodippili GC; Ritchie K; Low PS
    PLoS One; 2016; 11(9):e0162514. PubMed ID: 27598991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane phospholipid asymmetry in human thalassemia.
    Kuypers FA; Yuan J; Lewis RA; Snyder LM; Kiefer CR; Bunyaratvej A; Fucharoen S; Ma L; Styles L; de Jong K; Schrier SL
    Blood; 1998 Apr; 91(8):3044-51. PubMed ID: 9531618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection, characterization, and bioavailability of membrane-associated iron in the intact sickle red cell.
    Sugihara T; Repka T; Hebbel RP
    J Clin Invest; 1992 Dec; 90(6):2327-32. PubMed ID: 1469090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization, and immunoprecipitation studies of immune complexes from membranes of beta-thalassemic erythrocytes.
    Yuan J; Kannan R; Shinar E; Rachmilewitz EA; Low PS
    Blood; 1992 Jun; 79(11):3007-13. PubMed ID: 1586745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes.
    Mannu F; Arese P; Cappellini MD; Fiorelli G; Cappadoro M; Giribaldi G; Turrini F
    Blood; 1995 Sep; 86(5):2014-20. PubMed ID: 7655029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.